Compare RYTM & WTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RYTM | WTM |
|---|---|---|
| Founded | 2008 | 1980 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4B | 5.2B |
| IPO Year | 2017 | N/A |
| Metric | RYTM | WTM |
|---|---|---|
| Price | $111.98 | $2,044.86 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $127.31 | N/A |
| AVG Volume (30 Days) | ★ 966.4K | 21.2K |
| Earning Date | 11-04-2025 | 02-06-2026 |
| Dividend Yield | N/A | ★ 0.05% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 54.54 |
| Revenue | $174,334,000.00 | ★ $2,489,200,000.00 |
| Revenue This Year | $47.34 | N/A |
| Revenue Next Year | $57.18 | N/A |
| P/E Ratio | ★ N/A | $37.40 |
| Revenue Growth | ★ 54.92 | N/A |
| 52 Week Low | $45.91 | $1,648.00 |
| 52 Week High | $122.20 | $2,127.97 |
| Indicator | RYTM | WTM |
|---|---|---|
| Relative Strength Index (RSI) | 57.05 | 61.43 |
| Support Level | $109.99 | $2,036.00 |
| Resistance Level | $115.05 | $2,098.80 |
| Average True Range (ATR) | 5.20 | 38.23 |
| MACD | 0.60 | -3.61 |
| Stochastic Oscillator | 53.93 | 26.70 |
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.
White Mountains Insurance Group Ltd is engaged in the business of making opportunistic and value-oriented acquisitions of businesses and assets in the insurance, financial services, and related sectors, operating these businesses and assets through its subsidiaries and, if and when attractive exit valuations become available, disposing of these businesses and assets. The company conducts its business in five areas: property and casualty insurance and reinsurance, municipal bond reinsurance, capital solutions for asset and wealth management firms, property and casualty insurance distribution, and other operations.